Ascent Pharmaceuticals recalls
Ascent Pharmaceuticals has 3 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 15 Dec 2021.
Total recalls3since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Dec 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 67%Class III 1 33%
Why ascent pharmaceuticals is recalled
Product types
Brands
By year
All ascent pharmaceuticals recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg recalledHydrocodone Bitartrate And Acetaminophen | Ascent Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS II | Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg recalled | Ascent Pharmaceuticals | Other | Nationwide |
| Drug | CLASS III | Oxycodone Hydrochloride Tablets, USP 15 mg recalledOxycodone Hydrochloride | Ascent Pharmaceuticals | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.